Midazolam Infusion Preparation Guide
To prepare a midazolam infusion, dilute midazolam 5 mg/mL to a concentration of 0.5 mg/mL with 0.9% sodium chloride or 5% dextrose in water. 1
Standard Preparation Method
Gather supplies:
- Midazolam ampoules (5 mg/mL)
- Compatible diluent (0.9% sodium chloride or 5% dextrose in water)
- Appropriate infusion syringe/bag
- Sterile syringes and needles for drawing up medication
Calculate required concentration:
- Standard dilution: 0.5 mg/mL (as recommended by FDA labeling) 1
- Example: To prepare 50 mL of 0.5 mg/mL solution:
- Draw up 5 mL of midazolam (5 mg/mL = 25 mg total)
- Add 45 mL of diluent
- Final concentration: 25 mg in 50 mL = 0.5 mg/mL
Dosing guidelines for continuous infusion:
- Initial loading dose (if needed): 0.01-0.05 mg/kg (approximately 0.5-4 mg for typical adult)
- Maintenance infusion: 0.02-0.10 mg/kg/hr (1-7 mg/hr for typical adult) 1
- Titrate to desired sedation level by adjusting rate up or down by 25-50% of initial rate
Special Considerations
ICU sedation: Studies show effective plasma concentrations around 163-215 ng/mL, typically achieved with infusion rates of 0.06 mg/kg/hr 2
Dose adjustments:
Monitoring:
- Assess sedation at regular intervals
- Monitor oxygen saturation and respiratory status continuously
- Be prepared to provide respiratory support
- Have flumazenil available to reverse life-threatening respiratory depression 3
Titration Protocol
Initial titration:
- Start with recommended initial rate
- Assess sedation level every 10-15 minutes initially
- Adjust rate up or down by 25-50% based on response 1
Maintenance adjustment:
- Decrease rate by 10-25% every few hours to find minimum effective dose
- This minimizes drug accumulation and provides faster recovery 1
For inadequate sedation:
- Consider bolus dose equal to or double the hourly infusion rate
- If two bolus doses are required within an hour, double the infusion rate 3
Common Pitfalls and Cautions
Respiratory depression: Major side effect of midazolam, especially when combined with opioids. Deaths have been reported. 3
Prolonged sedation: Can occur due to altered kinetics in critically ill patients or accumulation of active metabolites 4
Withdrawal syndrome: Avoid sudden discontinuation after prolonged use. Taper over several days if used for extended periods 5
Drug interactions: Bioavailability increased by approximately 30% in patients using H2-receptor antagonists 3
Compatibility: Midazolam can be mixed in the same syringe as diamorphine for subcutaneous infusions 6
By following these guidelines, you can safely prepare and administer midazolam infusions while minimizing risks of complications and optimizing patient outcomes.